Crescent Capital BDC, Inc. CCAP
10.16 USD -0.22 (-2.12%)
Nov 11, 2026, 11:14 AM EST
10.08 Day range 10.35
8.40 52-week range 15.18
- YTD
- -27.69%
- 1 year
- -28.65%
News
benzinga.com Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $10 Wells Fargo analyst Finian O'Shea maintains Crescent Capital BDC (NASDAQ:CCAP) with a Equal-Weight and lowers the price target from $11 to $10.
fool.com Crescent Capital: 3 Key Takeaways for Long-Term Investors Crescent Capital authorized a $50 million share repurchase program. Direct lending for buyouts fell 60% year over year.
seekingalpha.com Crescent Capital BDC, Inc. (CCAP) Q3 2026 Earnings Call Transcript Crescent Capital BDC, Inc. ( CCAP ) Q3 2026 Earnings Call November 10, 2026 12:00 PM EST Company Participants Daniel McMahon - Senior VP & Head of Public Investor Relations Jason Breaux - CEO &…
marketbeat.com What Crescent Capital BDC (CCAP) Said on Its Q3 Earnings Call Crescent Capital BDC NASDAQ: CCAP reported a slight increase in third-quarter investment income and announced plans to buy back shares and form a joint venture as it works to reduce leverage.
benzinga.com Crescent Capital BDC Q3 2026 Earnings Call Transcript Crescent Capital BDC (NASDAQ:CCAP) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
zacks.com Wall Street Analysts Believe Crescent Capital BDC (CCAP) Could Rally 34.31%: Here's is How to Trade The average of price targets set by Wall Street analysts indicates a potential upside of 34.3% in Crescent Capital BDC (CCAP). While the effectiveness of this highly sought-after metric is…
zacks.com Crescent Capital BDC (CCAP) Surpasses Q3 Earnings and Revenue Estimates Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.46 per share a year ago.
globenewswire.com Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.34 Per Share and Announces a $50 Million Share Repurchase Program LOS ANGELES, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.37 per share and net income of $0.27…
benzinga.com Crescent Capital BDC Q3 Adj. EPS $0.37 Beats $0.35 Estimate, Sales $36.886M Beat $36.437M Estimate Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.35 by 2.78 percent. This is a 19.57 percent decrease over earnings of…
247wallst.com These 4 Overlooked Dividend Stocks Yield Up to 14%. Are They Worth Buying? A lender, a mortgage insurer, a Pennsylvania bank, and a Montana utility all pay dividends that earnings cover. But one of them just cut its payout, and its price tag tells you how nervous investors…
seekingalpha.com How We Are Thinking About Wide BDC Discounts The BDC sector trades at historically wide discounts, offering a 3.25% yield pickup versus NAV and significant margin of safety. Current sector discounts imply extreme default rates, unsupported by…
businesswire.com Crescent Capital Group Prices $406.9 Million Collateralized Loan Obligation LOS ANGELES--(BUSINESS WIRE)--Crescent Capital Group LP, one of the leading alternative credit investment firms, today announced the pricing of Atlas Senior Loan Fund XXVIII (“Atlas 28”), a $406.9…
benzinga.com This Nu Holdings Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday Analysts downgraded NU, BAK, CLLS and CBZ; price targets for NU, BAK and CLLS were cut sharply.
benzinga.com This Cellectis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday Analysts downgraded Banco Santander Brasil, Ribbon Communications, Cellectis, Scholar Rock, with mixed price-target changes.
benzinga.com This Chewy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday Analysts downgraded Chewy, Cooper Companies, AngloGold Ashanti and Crescent Capital BDC, cutting ratings and/or price targets.
benzinga.com B of A Securities Downgrades Crescent Capital BDC to Neutral, Lowers Price Target to $10.25 B of A Securities analyst Derek Hewett downgrades Crescent Capital BDC (NASDAQ:CCAP) from Buy to Neutral and lowers the price target from $13 to $10.25.
benzinga.com This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday WALL analysts changed outlook on top names. See upgrades, downgrades & initiations on analyst ratings page. Workday downgraded, price target cut.
benzinga.com Keefe, Bruyette & Woods Downgrades Crescent Capital BDC to Market Perform, Lowers Price Target to $12 Keefe, Bruyette & Woods analyst Paul Johnson downgrades Crescent Capital BDC (NASDAQ:CCAP) from Outperform to Market Perform and lowers the price target from $13 to $12.- benzinga.com Ladenburg Thalmann Maintains Buy on Crescent Capital BDC, Lowers Price Target to $14 Ladenburg Thalmann analyst Christopher Nolan maintains Crescent Capital BDC (NASDAQ:CCAP) with a Buy and lowers the price target from $15 to $14.
- benzinga.com B. Riley Securities Maintains Neutral on Crescent Capital BDC, Lowers Price Target to $12.5 B. Riley Securities analyst Sean-Paul Adams maintains Crescent Capital BDC (NASDAQ:CCAP) with a Neutral and lowers the price target from $13.5 to $12.5.
benzinga.com Crescent Capital BDC Q2 Adj. EPS $0.36 Misses $0.37 Estimate, Sales $36.323M Miss $37.316M Estimate Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.37 by 2.7 percent. This is a 21.74 percent decrease over earnings…
benzinga.com Alpha Buying: Wall Street Gave Up. Management Didn't. 
benzinga.com Keefe, Bruyette & Woods Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $13 Keefe, Bruyette & Woods analyst Paul Johnson maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and lowers the price target from $15 to $13.
benzinga.com The High-Yield Stocks the Smart Money Is Buying Right Now Smart credit team Ares Mgmt bought discounted BDCs aggressively in Q1 2026. They're not guessing but expressing conviction in 17 positions.
benzinga.com Oppenheimer Downgrades Crescent Capital BDC to Perform, Lowers Price Target to $16 Oppenheimer analyst Mitchel Penn downgrades Crescent Capital BDC (NASDAQ:CCAP) from Outperform to Perform and lowers the price target from $19 to $16.- benzinga.com Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $12 Wells Fargo analyst Finian O'Shea maintains Crescent Capital BDC (NASDAQ:CCAP) with a Equal-Weight and lowers the price target from $13 to $12.
- benzinga.com Crescent Capital BDC Q1 Adj. EPS $0.42, Inline, Sales $37.912M Miss $39.459M Estimate Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $0.42 per share which met the analyst consensus estimate. This is a 6.67 percent decrease over earnings of $0.45 per share from the…
benzinga.com Earnings Scheduled For May 13, 2026 - benzinga.com Keefe, Bruyette & Woods Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $15 Keefe, Bruyette & Woods analyst Paul Johnson maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and lowers the price target from $15.5 to $15.
- benzinga.com B. Riley Securities Initiates Coverage On Crescent Capital BDC with Neutral Rating, Announces Price Target of $13.5 B. Riley Securities analyst Sean-Paul Adams initiates coverage on Crescent Capital BDC (NASDAQ:CCAP) with a Neutral rating and announces Price Target of $13.5.
- benzinga.com Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $13 Wells Fargo analyst Finian O'Shea maintains Crescent Capital BDC (NASDAQ:CCAP) with a Equal-Weight and lowers the price target from $14 to $13.
benzinga.com Earnings Breakdown: Crescent Capital BDC Q4 
benzinga.com Crescent Capital BDC Q4 Adj. EPS $0.45 Beats $0.44 Estimate, Sales $40.812M Beat $40.076M Estimate Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.44 by 3.21 percent. This is a 18.18 percent decrease over earnings of…- benzinga.com Earnings Scheduled For February 25, 2026
- benzinga.com Oppenheimer Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $19 Oppenheimer analyst Mitchel Penn maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and lowers the price target from $20 to $19.
benzinga.com Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $14 Wells Fargo analyst Finian O'Shea maintains Crescent Capital BDC (NASDAQ:CCAP) with a Equal-Weight and lowers the price target from $15 to $14.- benzinga.com Keefe, Bruyette & Woods Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $15.5 Keefe, Bruyette & Woods analyst Paul Johnson maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and lowers the price target from $17 to $15.5.
- benzinga.com Crescent Capital BDC Q3 Adj. EPS $0.46 Misses $0.47 Estimate, Sales $41.352M Miss $42.231M Estimate Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $0.46 per share which missed the analyst consensus estimate of $0.47 by 2.13 percent. This is a 28.13 percent decrease over earnings…
- benzinga.com Earnings Scheduled For November 12, 2025
- benzinga.com Clear Street Initiates Coverage On Crescent Capital BDC with Buy Rating, Announces Price Target of $16.5 Clear Street analyst Mickey Schleien initiates coverage on Crescent Capital BDC (NASDAQ:CCAP) with a Buy rating and announces Price Target of $16.5.
- benzinga.com Earnings Scheduled For August 13, 2025
- benzinga.com Raymond James Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $17 Raymond James analyst Robert Dodd maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and lowers the price target from $20 to $17.
- benzinga.com Keefe, Bruyette & Woods Downgrades Crescent Capital BDC to Market Perform, Lowers Price Target to $17 Keefe, Bruyette & Woods analyst Ryan Lynch downgrades Crescent Capital BDC (NASDAQ:CCAP) from Outperform to Market Perform and lowers the price target from $18.5 to $17.
- benzinga.com What Analysts Are Saying About Crescent Capital BDC Stock
- benzinga.com Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $15 Wells Fargo analyst Finian O'Shea maintains Crescent Capital BDC (NASDAQ:CCAP) with a Equal-Weight and lowers the price target from $16 to $15.
- benzinga.com Crescent Capital BDC Q1 Net investment income per share $0.45 Misses $0.52 Estimate, Total investment income $42.13M Miss $45.08M Estimate Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $0.45 per share which missed the analyst consensus estimate of $0.52 by 13.46 percent. This is a 28.57 percent decrease over earnings…
- benzinga.com Earnings Scheduled For May 14, 2025
- benzinga.com What Analysts Are Saying About Crescent Capital BDC Stock
- benzinga.com Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $16 Wells Fargo analyst Finian O'Shea maintains Crescent Capital BDC (NASDAQ:CCAP) with a Equal-Weight and lowers the price target from $18 to $16.
- benzinga.com Earnings Scheduled For February 19, 2025